<http://schema.org/description>
"Imetelstat, a novel telomerase inhibiting drug, has been found to induce morphologic, molecular and clinical remissions in some patients with myelofibrosis a Mayo Clinic study has found. The results were presented today at the 2013 American Society of Hematology Annual Meeting in New Orleans."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2013-12-drug-morphologic-molecular-clinical-remissions.html>